Chinese Medical Journal (Aug 2025)

Equivalence of SYN008 versus omalizumab in patients with refractory chronic spontaneous urticaria: A multicenter, randomized, double-blind, parallel-group, active-controlled phase III study

  • Jingyi Li,
  • Yunsheng Liang,
  • Wenli Feng,
  • Liehua Deng,
  • Hong Fang,
  • Chao Ji,
  • Youkun Lin,
  • Furen Zhang,
  • Rushan Xia,
  • Chunlei Zhang,
  • Shuping Guo,
  • Mao Lin,
  • Yanling Li,
  • Shoumin Zhang,
  • Xiaojing Kang,
  • Liuqing Chen,
  • Zhiqiang Song,
  • Xu Yao,
  • Chengxin Li,
  • Xiuping Han,
  • Guoxiang Guo,
  • Qing Guo,
  • Xinsuo Duan,
  • Jie Li,
  • Juan Su,
  • Shanshan Li,
  • Qing Sun,
  • Juan Tao,
  • Yangfeng Ding,
  • Danqi Deng,
  • Fuqiu Li,
  • Haiyun Suo,
  • Shunquan Wu,
  • Jingbo Qiu,
  • Hongmei Luo,
  • Linfeng Li,
  • Ruoyu Li,
  • Lishao Guo

DOI
https://doi.org/10.1097/cm9.0000000000003593
Journal volume & issue
Vol. 138, no. 16
pp. 2040 – 2042

Abstract

Read online

No abstracts available.